said John T. Treace, CEO, Founder and Board Member of Treace. Surgeon design team member, Amber Shane, DPM, FACFAS, Department Chair and Residency Faculty at AdventHealth commented, “The ...

“The SpeedAkin™ implant leverages our proprietary SpeedPlate™ technology in a differentiated Akin osteotomy solution, further expanding our best-in-class bunion focused portfolio.” said John T. Treace ...

“We close 2024 with new product announcements and 12% annual revenue growth – positioning us for continued growth in 2025 and beyond,” said John T. Treace, CEO, Founder and Board Member of ...

"We're excited to expand our best-in-class bunion-focused portfolio with the SpeedAkin implant, furthering our commitment to improving patient outcomes," said John T. Treace, CEO, Founder ...

"We close 2024 with new product announcements and 12% annual revenue growth - positioning us for continued growth in 2025 and beyond,” said John T. Treace, CEO, Founder and Board Member of Treace.